LAURUS LABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 437.4 INR | +0.84% |
|
+1.86% | +1.69% |
| 09:49am | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| Apr. 25 | Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.8B | ||||||
| 588B | ||||||
| 364B | ||||||
| 326B | ||||||
| 285B | ||||||
| 239B |
